Bioadaptives, Inc. (BDPT) EPS (Basic) (2013 - 2026)

Bioadaptives (BDPT) posted EPS (Basic) of -$0.0 for Q1 2026, up 90.38% sequentially from -$0.0 in Q4 2025, and up 75.17% YoY from -$0.0 in Q1 2025.

Bioadaptives, Inc. (BDPT) EPS (Basic) (2013 - 2026) Analysis & Trends

Bioadaptives has reported EPS (Basic) for 13 years, with the latest figure at -$0.0 in Q1 2026.

Quarterly EPS (Basic) rose 75.17% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.01 (up 17.85% YoY) and the FY2025 annual result came in at -$0.01, up 92.52% from the prior year.
EPS (Basic) rose to -$0.0 in Q1 2026 per BDPT's latest filing, from -$0.0 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.0 in Q3 2024 and troughed at -$0.05 in Q4 2024.
A 5-year average of -$0.0 and a median of -$0.0 in 2026 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 96.17% in 2023, then tumbled 24043.63% in 2024.
Over 5 years, EPS (Basic) stood at -$0.0 in 2022, then surged by 48.79% to -$0.0 in 2023, then sank by 24043.63% to -$0.05 in 2024, then jumped by 90.44% to -$0.0 in 2025, then soared by 90.38% to -$0.0 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data